Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lotta Joutsi-Korhonen

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Thrombosis Research|January 4, 2011
Interaction between clinic and laboratoryElina Armstrong, Lotta Joutsi-Korhonen, Riitta Lassila
Thrombosis Research|February 26, 2010
Comparison of monitoring methods for lepirudin: impact of warfarin and lupus anticoagulantBirgitta Salmela, Lotta Joutsi-Korhonen, Ellen Saarela, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysisBirgitta Salmela, Lotta Joutsi-Korhonen, Elina Armstrong, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
New insights into von Willebrand disease and platelet functionTímea Szántó, Lotta Joutsi-Korhonen, Hans Deckmyn, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 2010
Amniotic lamellar body counts determined with the Sysmex XE-2100 analyzer to predict fetal lung maturity during diabetic and other complicated pregnanciesLotta Joutsi-Korhonen, Ansa Aitokallio-Tallberg, Erja Halmesmäki, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 26, 2012
Alterations of sympathetic nervous system, coagulation and platelet function in gestational diabetesMaritta Pöyhönen-Alho, Lotta Joutsi-Korhonen, Riitta Lassila, et al.
Clinical Chemistry|February 5, 2013
Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratoriesTuukka A Helin, Anja Pakkanen, Riitta Lassila, et al.
Research and Practice in Thrombosis and Haemostasis|April 19, 2021
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated ThrombogramTuukka A Helin, Marja Lemponen, Riitta Lassila, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant TestingPaula Savola, Marja Lemponen, Lotta Joutsi-Korhonen, et al.
Diagnostics (Basel, Switzerland)|May 16, 2023
Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic ProcedureTuukka Helin, Tomi Tirri, Heidi Korkala, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Thrombosis Research|January 4, 2011
Interaction between clinic and laboratoryElina Armstrong, Lotta Joutsi-Korhonen, Riitta Lassila
Thrombosis Research|February 26, 2010
Comparison of monitoring methods for lepirudin: impact of warfarin and lupus anticoagulantBirgitta Salmela, Lotta Joutsi-Korhonen, Ellen Saarela, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysisBirgitta Salmela, Lotta Joutsi-Korhonen, Elina Armstrong, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
New insights into von Willebrand disease and platelet functionTímea Szántó, Lotta Joutsi-Korhonen, Hans Deckmyn, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 2010
Amniotic lamellar body counts determined with the Sysmex XE-2100 analyzer to predict fetal lung maturity during diabetic and other complicated pregnanciesLotta Joutsi-Korhonen, Ansa Aitokallio-Tallberg, Erja Halmesmäki, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 26, 2012
Alterations of sympathetic nervous system, coagulation and platelet function in gestational diabetesMaritta Pöyhönen-Alho, Lotta Joutsi-Korhonen, Riitta Lassila, et al.
Clinical Chemistry|February 5, 2013
Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratoriesTuukka A Helin, Anja Pakkanen, Riitta Lassila, et al.
Research and Practice in Thrombosis and Haemostasis|April 19, 2021
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated ThrombogramTuukka A Helin, Marja Lemponen, Riitta Lassila, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant TestingPaula Savola, Marja Lemponen, Lotta Joutsi-Korhonen, et al.
Diagnostics (Basel, Switzerland)|May 16, 2023
Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic ProcedureTuukka Helin, Tomi Tirri, Heidi Korkala, et al.
Pageof 6